For this purpose, we compared serum hepcidin levels and hepatic hepcidin antimicrobial peptide (HAMP) gene expressions in NAFLD patients with various degrees of iron overload, to those of patients with other forms of acquired or genetic iron overload. The gene discussed is HAMP; the disease is metabolic dysfunction-associated steatotic liver disease.